Tolerability and discontinuation rates in teriflunomide-treated patients: A real-world clinical experience

OBJECTIVES: To assess the real-world tolerability of teriflunomide in multiple sclerosis (MS) patients from a large Canadian MS Centre of Care to determine whether previously treated (PT) patients have different tolerability thresholds than treatment-naive (TN) patients, leading to differing discont...

Descripción completa

Detalles Bibliográficos
Autores principales: Alnajashi, Hind A., Alshamrani, Foziah J., Freedman, Mark S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Riyadh : Armed Forces Hospital 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8015587/
https://www.ncbi.nlm.nih.gov/pubmed/30007995
http://dx.doi.org/10.17712/nsj.2018.3.20180003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8015587/
https://www.ncbi.nlm.nih.gov/pubmed/30007995
http://dx.doi.org/10.17712/nsj.2018.3.20180003

Ejemplares similares